COVAXIN to be 77.8% effective against symptomatic COVID-19
Bharat Biotech’s COVAXIN® Phase III data published in The Lancet AMN / Hyderabad The Lancet peer-review confirmed the efficacy analysis which demonstrates COVAXIN® to be effective against COVID-19. It noted…
